Accula System for SARS-CoV-2 - Brochure
The Accula System has received FDA Emergency Use Authorization (EUA) for SARS-CoV-2 (the virus responsible for COVID-19) in vitro diagnostic testing. It is available now for use in patient care settings. Easy and fast, our qualitative PCR-based test provides visual results within ~ 30 minutes.
